Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors

por Schimanski, Carl C, Galle, Peter R, Moehler, Markus
Publicado 2008

Colon cancer and the immune system: The role of tumor invading T cells

por Waldner, Maximilian, Schimanski, Carl C, Neurath, Markus F
Publicado 2006

Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophyl...

por WEHLER, THOMAS C., CAO, YANG, GALLE, PETER R., THEOBALD, MATTHIAS, MOEHLER, MARKUS, SCHIMANSKI, CARL C.
Publicado 2012

Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report

por Sprinzl, Martin F, Schimanski, Carl C, Moehler, Markus, Schadmand-Fischer, Simin, Galle, Peter R, Kanzler, Stephan
Publicado 2006

VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab

por Moehler, Markus, Frings, Christian, Mueller, Annett, Gockel, Ines, Schimanski, Carl C, Biesterfeld, Stefan, Galle, Peter R, Holtmann, Martin H
Publicado 2008

Last line therapy with sorafenib in colorectal cancer: A retrospective analysis

por Martchenko, Ksenia, Schmidtmann, Irene, Thomaidis, Thomas, Thole, Verena, Galle, Peter R, Becker, Marc, Möhler, Markus, Wehler, Thomas C, Schimanski, Carl C
Publicado en World J Gastroenterol (2016)

Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases

por Desuki, Alexander, Staib, Frank, Gockel, Ines, Moehler, Markus, Lang, Hauke, Biesterfeld, Stefan, Maderer, Annett, Galle, Peter R., Berger, Martin R., Schimanski, Carl C.
Publicado en Can J Gastroenterol Hepatol (2019)

The T‐box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer

por Atreya, Imke, Schimanski, Carl C, Becker, Christoph, Wirtz, Stefan, Dornhoff, Heike, Schnürer, Elke, Berger, Martin R, Galle, Peter R, Herr, Wolfgang, Neurath, Markus F
Publicado 2007

Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

por Wehler, Thomas C., Graf, Claudine, Möhler, Markus, Herzog, Jutta, Berger, Martin R., Gockel, Ines, Lang, Hauke, Theobald, Matthias, Galle, Peter R., Schimanski, Carl C.
Publicado 2013

Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

por Wehler, Thomas C., Graf, Claudine, Möhler, Markus, Herzog, Jutta, Berger, Martin R., Gockel, Ines, Lang, Hauke, Theobald, Matthias, Galle, Peter R., Schimanski, Carl C.
Publicado 2013

Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues

por ALLAMI, RISALA HUSSAIN, GRAF, CLAUDINE, MARTCHENKO, KSENIA, VOSS, BEATRICE, BECKER, MARC, BERGER, MARTIN R., GALLE, PETER R., THEOBALD, MATTHIAS, WEHLER, THOMAS C., SCHIMANSKI, CARL C.
Publicado en Oncol Lett (2016)

Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma

por Gockel, Ines, Schimanski, Carl C, Heinrich, Christian, Wehler, T, Frerichs, K, Drescher, Daniel, von Langsdorff, Christian, Domeyer, Mario, Biesterfeld, Stefan, Galle, Peter R, Junginger, Theodor, Moehler, Markus
Publicado 2006

Strong Expression of Chemokine Receptor CXCR4 by Renal Cell Carcinoma Correlates with Advanced Disease

por Wehler, Thomas C., Graf, Claudine, Biesterfeld, Stefan, Brenner, Walburgis, Schadt, Jörg, Gockel, Ines, Berger, Martin R., Thüroff, Joachim W., Galle, Peter R., Moehler, Markus, Schimanski, Carl C.
Publicado 2008

Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy

por Wehler, Thomas C., Hamdi, Swaantje, Maderer, Annett, Graf, Claudine, Gockel, Ines, Schmidtmann, Irene, Hainz, Michael, Berger, Martin R., Theobald, Matthias, Galle, Peter R., Moehler, Markus, Schimanski, Carl C.
Publicado 2012

Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients

por Moehler, Markus, Sprinzl, Martin F, Abdelfattah, Murad, Schimanski, Carl C, Adami, Bernd, Godderz, Werner, Majer, Klaus, Flieger, Dimitri, Teufel, Andreas, Siebler, Juergen, Hoehler, Thomas, Galle, Peter R, Kanzler, Stephan
Publicado 2009

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of th...

por Moehler, Markus, Gockel, Ines, Roessler, Hans-Peter, Arnold, Dirk, Trarbach, Tanja, Thomaidis, Thomas, Klautke, Gunther, Rödel, Claus, Brenner, Baruch, Lang, Hauke, Galle, Peter R, Schimanski, Carl C, Schmidberger, Heinz
Publicado 2013

Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma-a rationale for a molecular targeting strategy?

por Drescher, Daniel, Moehler, Markus, Gockel, Ines, Frerichs, Kirsten, Müller, Annett, Dünschede, Friedrich, Borschitz, Thomas, Biesterfeld, Stefan, Holtmann, Martin, Wehler, Thomas, Teufel, Andreas, Herzer, Kerstin, Fischer, Thomas, Berger, Martin R, Junginger, Theodor, Galle, Peter R, Schimanski, Carl C
Publicado 2007